Science Angel Syndicate is a community of entrepreneurs and investors that sources scientific discoveries with potential global impact. The organization focuses on assessing and identifying promising frontier scientific companies.

Science Angel Syndicate

We are Investors and Scientists
We source world-class scientific discoveries, provide unique scientific due diligence and help our members to identify exceptional investment opportunities. Our collective knowledge helps our members invest in the most exciting companies of tomorrow, founded by leading scientists at the forefront of their fields. We aim to discover companies that will grow rapidly and tackle the most important global challenges.

It’s been a fantastic year for the Science Angel Syndicate team and portfolio companies. We wanted to take a minute to highlight some key achievements, ahead of the launch of some exciting news in January (further updates to follow in the New Year).

Since inception in Sep 2021 we have reviewed >500 companies, made 18 investments into 14 companies and deployed £6m.

Deals - In 2023, we completed 7 investment deals into QV Bioelectronics, EnsiliTech, OSSTEC, Halo Therapeutics, Albotherm, including follow-on investment into MitoRx Therapeutics and ARGONAUTE RNA LIMITED.

Portfolio Highlights - Our entire portfolio has made significant strides in the last year at a time when macro conditions were challenging. We will be releasing a portfolio summary in the new year to highlight the progress these companies have made!

Team - we’ve expanded our investment team, welcoming Curran Kalha, Ph.D. earlier this year.

Community - Bringing together the Science Angel Syndicate community at our pitch events, summer party and most recently, at our Christmas Party in London in December. It was a fantastic opportunity to bring together our team, founders, investors and partners, showcase some exceptional investment opportunities in the pipeline, celebrate our milestones so far and look towards an exciting 2024.

We have exciting plans in place for 2024 that will see us rapidly scaling our team and investment capabilities. Watch this space for exciting updates in Jan.

From all of us at Science Angel Syndicate, we hope you have a lovely Christmas and New Year!

Dr. Thomas Fudge and Llŷr Anwyl were the first entrepreneurs we backed at Science Angel Syndicate in 2021 when we made an investment into WASE LIMITED who had a vision for the valorisation of wastewater in SME industries.

Excited is an understatement! To see this company announce its latest £8.5m round with coverage in TechCrunch is great validation of the early bet we placed. 

Thomas and Llyr have brought on some exceptional investors on board as part of this round Extantia, ENGIE New Ventures, Hitachi Ventures and WEPA Ventures. Our new rebranded Syndicate Empirical Ventures also participated in this round alongside follow-on from Elbow Beach Capital.

Of course this is still just the beginning of the development of this technology and we stand by ready to continue supporting WASE.

It also marked the start of an important relationship with Elbow Beach Capital who made their first fund investment into WASE LIMITED. Working alongside Jonathan Pollock at the board level to support the development of WASE further highlighted the importance of having the right investors on your captable. 

Richard Gueterbock James Astor Dr Ben Miles, Ph.D. James Savage James K. Richard Tompkins James Kraft Charles Grimsdale Adam Hillier Dr Ben Miles, Ph.D. Alexander Fink Keith Lipman Claudia Fryer Curran Kalha, Ph.D.

https://lnkd.in/ezHhUZ-V

A fantastic day representing Spin Up Science and Science Angel Syndicate at #BioCap yesterday at Alderley Park!

It was great showcase of some of the exceptional life science companies in the North, with insightful founder journeys and investor panels, as well as a sneak peak into exciting opportunities in the pipeline. I had fantastic time chatting to founders and catching up with connections old and new. Thanks Stella James, Dave Holmes and the rest of the Bionow team for putting together such a wonderful event! 

If I missed you, and you're an early stage life science company founder, whether you're actively fundraising or not, do reach out for a conversation on how Spin Up Science Ventures or Science Angel Syndicate can help

#lifescience #startups #investment #ventures

Co-founder Ben Miles taking a closer look at First Light Fusion, a superb deep dive and well worth a watch!

Science Angel Syndicate has participated in the most recent funding round for portfolio company MitoRx Therapeutics. Please reach out to Jon Rees if you would like to learn about their first-in-class, first-in-mechanism hydrogen sulfide donors for treating a range of degenerative diseases.

Read all about the future of broadband infrastructure from SAS director Ben Miles and his recent trip to Dubai hosted by Huawei

SCIE

COM:SCIENCEANGELSYNDICATE

Science Angel Syndicate